ECI Intelligence · Regulatory Map
European Cannabis Regulatory Map
Licensing status, GMP requirements and prescribing pathways across 32 European and export markets. Click any market for full detail. Updated June 2026.
Licensing status, GMP requirements and prescribing pathways across 32 European and export markets. Click any market for full detail. Updated June 2026.
| Market | Status | GMP Required | Prescribing | Authority | Notes |
|---|---|---|---|---|---|
| Germany | Licensed and Active | Yes | Available | BfArM | Largest European market. Full EU GMP required for all imports. BfArM conducts in... |
| Netherlands | Licensed and Active | Yes | Available | CBG / IGJ | Bureau Medicinale Cannabis oversees state-produced cannabis. Import authorisatio... |
| Portugal | Licensed and Active | Yes | Available | Infarmed | Pioneer medical cannabis legislation. Infarmed actively engaged with regulatory ... |
| Denmark | Licensed and Active | Yes | Available | DKMA | Four-year pilot programme now permanent. Full EU GMP required. DKMA issues impor... |
| Luxembourg | Licensed and Active | Yes | Available | Direction de la Santé | Medical cannabis programme operational. EU GMP certification required for all li... |
| Malta | Licensed and Active | Yes | Available | MCCAA / Superintendent | First EU country to legalise adult-use alongside medical. Medical cannabis requi... |
| Czech Republic | Licensed and Active | Yes | Available | SÚKL | Domestic cultivation licensed. Import authorisations active. GMP required. Growi... |
| Poland | Licensed and Active | Yes | Restricted | URPL | Medical cannabis legal since 2017. Import-dependent market. GMP required but rei... |
| Italy | Licensed and Active | Yes | Restricted | AIFA | Military facility (Florence) produces domestically. Imports authorised. GMP requ... |
| Croatia | Licensed and Active | Yes | Available | HALMED | Medical cannabis programme since 2015. GMP required. Relatively small but establ... |
| Greece | Licensed and Active | Yes | Available | EOF | Export-oriented market with significant licensed production capacity. EU GMP req... |
| Austria | Licensed and Active | Yes | Restricted | BASG | Medical cannabis available via magistral preparations and licensed products. GMP... |
| Finland | Licensed and Active | Yes | Restricted | Fimea | Medical cannabis via special licence. GMP required. Conservative prescribing env... |
| Norway | Licensed and Active | Yes | Restricted | NoMA | Not EU member but EEA-aligned. EU GMP accepted. Medical cannabis via named patie... |
| Switzerland | Licensed and Active | Yes | Available | Swissmedic | Non-EU. Swissmedic requirements broadly aligned with EU GMP. Established medical... |
| Spain | Licensed but Limited | Yes | Restricted | AEMPS | AEMPS consultation on medical cannabis regulatory framework ongoing (2026). Magi... |
| France | Licensed but Limited | Yes | Restricted | ANSM | National pilot programme extended. GMP required for pilot supply. Framework for ... |
| Belgium | Licensed but Limited | Yes | Restricted | FAMHP | Medical cannabis available via named patient pathway. GMP required. Broader fram... |
| Ireland | Licensed but Limited | Yes | Restricted | HPRA | Medical Cannabis Access Programme operational. Five products authorised. GMP req... |
| Sweden | Licensed but Limited | Yes | Restricted | MPA | Medical cannabis available but highly restricted. Full EU GMP required. Reimburs... |
| United Kingdom | Licensed but Limited | Yes | Restricted | MHRA | Post-Brexit MHRA framework. UK GMP (equivalent to EU GMP) required. Specialist c... |
| Romania | Emerging | No | None | ANM | No active medical cannabis programme. Legislation under discussion. |
| Hungary | Emerging | No | None | OGYÉI | No medical cannabis programme. Controlled substance only. |
| Slovakia | Emerging | No | None | ŠÚKL | No medical cannabis programme. Framework not yet developed. |
| Slovenia | Emerging | No | None | JAZMP | Pilot discussion commenced but no active programme. |
| Estonia | Emerging | No | None | SAM | No active programme. Baltic market watching Finnish and German developments. |
| Latvia | Emerging | No | None | ZVA | No active medical cannabis programme. |
| Lithuania | Emerging | No | None | VVKT | No active programme. |
| Bulgaria | Emerging | No | None | BDA | No active medical cannabis programme. |
| Israel | Export Market | Yes | N/A (Export) | IMCA | Leading global cannabis exporter. IMCA GMP broadly equivalent to EU GMP. Major s... |
| Canada | Export Market | Yes | N/A (Export) | Health Canada | Major global cannabis exporter. EU GMP certification required for European marke... |
| Australia | Export Market | Yes | N/A (Export) | TGA | Growing export market. TGA GMP equivalent to EU GMP. Import authorisation requir... |